NO304830B1 - Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem - Google Patents

Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem

Info

Publication number
NO304830B1
NO304830B1 NO951736A NO951736A NO304830B1 NO 304830 B1 NO304830 B1 NO 304830B1 NO 951736 A NO951736 A NO 951736A NO 951736 A NO951736 A NO 951736A NO 304830 B1 NO304830 B1 NO 304830B1
Authority
NO
Norway
Prior art keywords
drugs
poly
diagnostics
manufacture
well
Prior art date
Application number
NO951736A
Other languages
English (en)
Other versions
NO951736L (no
NO951736D0 (no
Inventor
Jan-Robert Schwark
Heinz-Werner Kleemann
Hans-Jochen Lang
Andreas Weichert
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO951736D0 publication Critical patent/NO951736D0/no
Publication of NO951736L publication Critical patent/NO951736L/no
Publication of NO304830B1 publication Critical patent/NO304830B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO951736A 1994-05-05 1995-05-04 Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem NO304830B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4415873A DE4415873A1 (de) 1994-05-05 1994-05-05 Substituierte bizyklische Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (3)

Publication Number Publication Date
NO951736D0 NO951736D0 (no) 1995-05-04
NO951736L NO951736L (no) 1995-11-06
NO304830B1 true NO304830B1 (no) 1999-02-22

Family

ID=6517371

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951736A NO304830B1 (no) 1994-05-05 1995-05-04 Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem

Country Status (19)

Country Link
US (1) US6093729A (no)
EP (1) EP0682017B1 (no)
JP (1) JP3774771B2 (no)
KR (1) KR950032129A (no)
CN (1) CN1117045A (no)
AT (1) ATE183179T1 (no)
AU (1) AU693861B2 (no)
CA (1) CA2148666A1 (no)
DE (2) DE4415873A1 (no)
DK (1) DK0682017T3 (no)
ES (1) ES2136767T3 (no)
FI (1) FI952117A (no)
GR (1) GR3031539T3 (no)
HU (1) HUT72089A (no)
IL (1) IL113606A0 (no)
NO (1) NO304830B1 (no)
NZ (1) NZ272058A (no)
TW (1) TW429252B (no)
ZA (1) ZA953588B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19548812A1 (de) * 1995-12-27 1997-07-03 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikaments zur Atemstimulation
NZ314105A (en) * 1996-02-02 1997-12-19 Sumitomo Pharma Guanidine derivative substituted with a substituted indole which is peri condensed with a heterocyclic ring
DE19621483A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 2-Naphthoylguanidine, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621482A1 (de) * 1996-05-29 1997-12-04 Hoechst Ag Substituierte 1-Naphthoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CA2283404A1 (en) 1997-03-06 1998-09-11 Jun Sasamori Cycloalka¬b|pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
WO1999042442A1 (fr) * 1998-02-20 1999-08-26 Takeda Chemical Industries, Ltd. Derives d'aminoguanidine hydrazone, procedes de production, et medicaments a base de ces derives
US6706732B1 (en) 1999-06-03 2004-03-16 Takeda Chemical Industries, Ltd. Nasal preparation of guanidinoimino quinoline derivatives
NZ544671A (en) * 2003-06-26 2009-02-28 Biotron Ltd Antiviral compounds and methods
CN104370813A (zh) * 2014-10-22 2015-02-25 上海大学 异喹啉-6-甲醛的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
ATE158278T1 (de) * 1992-02-15 1997-10-15 Hoechst Ag Ortho-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
ATE198328T1 (de) * 1992-09-28 2001-01-15 Hoechst Ag Antiarrhythmische und cardioprotektive substituierte 1(2h)-isochinoline, verfahren zu deren herstellung, diese enthaltende arzneimittel und ihre anwendung für die herstellung eines arzneimittels zur behandlung von herzinsuffizienzen

Also Published As

Publication number Publication date
DK0682017T3 (da) 1999-12-13
DE59506564D1 (de) 1999-09-16
ES2136767T3 (es) 1999-12-01
NZ272058A (en) 1996-02-27
AU1786195A (en) 1995-11-16
EP0682017A1 (de) 1995-11-15
US6093729A (en) 2000-07-25
IL113606A0 (en) 1995-08-31
GR3031539T3 (en) 2000-01-31
EP0682017B1 (de) 1999-08-11
ATE183179T1 (de) 1999-08-15
JP3774771B2 (ja) 2006-05-17
CN1117045A (zh) 1996-02-21
DE4415873A1 (de) 1995-11-09
FI952117A (fi) 1995-11-06
KR950032129A (ko) 1995-12-20
NO951736L (no) 1995-11-06
NO951736D0 (no) 1995-05-04
AU693861B2 (en) 1998-07-09
JPH0841028A (ja) 1996-02-13
FI952117A0 (fi) 1995-05-03
CA2148666A1 (en) 1995-11-06
HUT72089A (en) 1996-03-28
TW429252B (en) 2001-04-11
ZA953588B (en) 1996-06-16

Similar Documents

Publication Publication Date Title
NO304830B1 (no) Substituerte bicykliske heteroaroylguanidiner, deres anvendelse for fremstilling av medikament eller diagnostikum sÕvel som medikamenter inneholdende dem
MX9100062A (es) Composiciones en polvo para revestimiento para la fabricacion de las mismas
FI924310A (fi) Nya 2-substituerade indan-2-karboxialkylderivat anvaendbara som inhibitorer av enkefalinas och ace
ES2079534T3 (es) Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados.
FI924311A0 (fi) Nya 2-substituerade indan-2 -merkaptoacetylamidderivat anvaendbara som inhibitorer av enkefalinas och ace.
MX9200344A (es) Derivados de benzamida, proceso para su preparacion y composicion farmaceutica que los contiene.
SE8902326L (sv) Karboxamidfoereningar, foerfaranden foer framstaellning av dem och farmceutiska kompositioner som innehaaller dem
DK0702010T3 (da) Hidtil ukendte benzopyranderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
DK160981C (da) Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
DK160788D0 (da) 2-oen-phenyl(eller phenoxy)alkyl-n-methyl-aminoaaindan-forbindelser, anvendelse af sulfonamido-derivater blandt disse til fremstilling af antiarrhythmia-laegemidler og farmaceutiske praeparater indeholdende sulfonamiderne
DK50086D0 (da) 3-phenyl-tetrahydropyridinderivater
MX9301298A (es) Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK81184A (da) Anvendelse af i 2-stillingen med (substituerede) aminogrupper substituerede 4-dl-alkylester-alfa-alaninyl-6-chlor-s-triaziner som herbicider, isaer mod flyvehavre
PT861837E (pt) Novos compostos de 2-amino-indano processo para a sua preparacao e as composicoes farmaceuticas que os contem
ES499154A0 (es) Procedimiento para la preparacion de fenil eteres y tioeteres sustituidos y sus sales.
DK671087A (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
ES542061A0 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
ES501194A0 (es) Procedimiento para la modificacion de las propiedades de re-flexion de superficies de piezas opticas
DK0477552T3 (da) Anvendelse af 10-ring-lactoner som lipidregulatorer
DK0521967T3 (da) Ny anvendelse af bambuterol
ITRM920039A1 (it) Uso dell'acido ialuronico lubrificante di protesi oculari.
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
AU3017397A (en) New bisimide compounds, process for preparing them and pharmaceutical compositions containing them
MX23335A (es) Derivados de acido glutarico y procedimiento para su preparacion.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees